Alex Lobo
Investor Relations, PrecisionAQ
Replay available
Inhibikase Therapeutics, Inc. (IKT) Q2 2024 Earnings Call
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q2 2024 earnings conference call, held 2024-08-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Milton Werner
Chief Executive Officer
Garth Lees-Ralph
Chief Financial Officer
Jason McCarthy
Analyst, The Maxim Group
Ed White
Analyst, HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inhibikase Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.072 Greetings, and welcome to the Inhibicase Therapeutics Second Quarter 2024 Financial 00:00:05.072 -- 00:00:10.175 Results Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.175 -- 00:00:13.977 A brief question and answer session will follow the formal presentation. 00:00:13.977 -- 00:00:18.400 If anyone should require operator assistance during the conference, please press star 00:00:18.400 -- 00:00:24.083 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:24.083 -- 00:00:29.602 It is now my pleasure to introduce your host, Alex Lobo, PrecisionAQ Investor Relations. 00:00:29.602 -- 00:00:32.903 Thank you, sir. You may begin. 00:00:34.145 -- 00:00:38.648 Good morning, and welcome to Inhibit Case Therapeutics second quarter 2024 financial 00:00:38.648 -- 00:00:41.830 results conference call and audio webcast. 00:00:41.830 -- 00:00:46.994 With me today is Dr. Milton Werner, Chief Executive Officer, and Garth Lees-Ralph, Chief 00:00:46.994 -- 00:00:49.175 Financial Officer. 00:00:49.175 -- 00:00:53.478 On August 14th, Inhibit Case issued a press release announcing financial results, but 00:00:53.478 -- 00:00:57.009 the second quarter ended June 30th, 2024. 00:00:57.110 -- 00:01:01.271 We encourage everyone to read to yesterday's press release, as well as Inhibit Case's 00:01:01.271 -- 00:01:06.832 quarterly report on Form 10-Q, which has been filed with the SEC. 00:01:06.832 -- 00:01:11.494 The company's press release and Form 10-Q are also available on Inhibit Case's website 00:01:11.494 -- 00:01:13.614 at inhibitcase.com. 00:01:14.014 -- 00:01:17.695 In addition, this conference call is being webcast through the investor relations section 00:01:17.695 -- 00:01:22.236...